Bone Loss Recruiting Phase 3 Trials for Risedronic acid (DB00884)

Back to Bone Loss

Also known as: Osteopenia / Osteopenia (disorder) / Osteopenia (morphologic abnormality) / Osteopaenia

IndicationStatusPhase
DBCOND0031952 (Bone Loss)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04922333Bisphosphonate Use to Mitigate Bone Loss Secondary to Bariatric SurgeryPrevention